Option chain shows key data for Carmell's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Carmell.

Carmell (NASDAQ:CTCX) Stock, Option Chain

Carmell Therapeutics

Carmell Corp is a bio-aesthetics company that utilizes the Carmell Secretome to support skin and hair health. Its cosmetic skincare product portfolio includes Carmell G.L.E.E and various others in pipeline such as Youth restoring formula, Ultra-brightening formula, Ultra-hydrating formula, and Rapid Recovery formula among others. The company has one operating segment, principally the business of developing and commercializing bio-aesthetics and its bone and tissue healing products.

Wall-Street-ai7-1

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

CRNC

CTCX

CYCC

DOGZ

IDAI

NITO

Nasdaq Surges Over 1%; Cerence Shares Spike Higher

Wall Street Bulls

Dow Jumps Over 100 Points; ISM Manufacturing PMI Increases In December

Crude-oil-4-logo

NMRA

TSLA

Crude Oil Surges 2%; Tesla Shares Plummet

Carmell Corp

Contracts

Press Releases

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

Financing

Carmell Announces $3.0 Million Private Placement

Carmell Announces Successful Closing of $3.0 Million Private Placement

Management

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

General

Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community

Blushington Announces National Advisory Board to Guide Franchise Expansion

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

Carmell Announces Closing of Elevai Skincare Acquisition

AIM ImmunoTech

Ainos

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

BioCardia

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

bioAffinity Technologies, Inc. - Common Stock

bioAffinity Technologies

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Carmell

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Ensysce Biosciences

Galecto

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Portage Biotech

Sunshine Biopharma

SILO Pharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Soligenix

Turnstone Biologics

Xenetic Biosciences

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals

Comments

Carmell

Carmell (CTCX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga